CHORD THERAPEUTICS S A R L has a total of 13 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2015. It filed its patents most often in EPO (European Patent Office), United Kingdom and United States. Its main competitors in its focus markets pharmaceuticals are DAK LAB AS, HAVAH THERAPEUTICS PTY LTD and SHURDOV MIKHAIL ARKAD EVICH.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 2 | |
#2 | United Kingdom | 2 | |
#3 | United States | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Australia | 1 | |
#6 | Canada | 1 | |
#7 | EAPO (Eurasian Patent Organization) | 1 | |
#8 | Hungary | 1 | |
#9 | Serbia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Rejdak Konrad | 11 |
#2 | Roach Arthur Henry | 8 |
#3 | Konrad Rejdak | 1 |
Publication | Filing date | Title |
---|---|---|
GB202019460D0 | Use of cladribine for treating immune brain disease | |
GB201711800D0 | Use of cladribine for treating autoimmune neuromuscular disease | |
EA031244B1 | Use of cladribine for treating neuromyelitis optica |